Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
44
XWEL Quote, Financials, Valuation and Earnings
Last price:
$1.06
Seasonality move
:
-16.2%
Day range:
$1.01 - $1.04
52-week range:
$0.70 - $2.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.15x
P/B ratio:
0.66x
Volume:
20.6K
Avg. volume:
37.5K
1-year change:
-38.92%
Market cap:
$5.4M
Revenue:
$33.9M
EPS (TTM):
-$4.02
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, XWELL has 586.28% upside to fair value with a price target of -- per share.
XWEL vs. S&P 500
-
Over the past 5 trading days, XWELL has overperformed the S&P 500 by 2.45% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
XWELL does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
XWELL revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter XWELL reported revenues of $7M.
Earnings Growth
-
XWELL has grown year-over-year earnings for 0 quarters straight. In the most recent quarter XWELL reported earnings per share of -$1.00.
Enterprise value:
3.6M
EV / Invested capital:
--
Price / LTM sales:
0.15x
EV / EBIT:
--
EV / Revenue:
0.11x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.27x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$7.6M
Return On Assets:
-60.42%
Net Income Margin (TTM):
-59.2%
Return On Equity:
-153.74%
Return On Invested Capital:
-153.74%
Operating Margin:
-44.97%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $39M | $31.8M | $32.2M | $8.7M | $7M | |
| Gross Profit | $3.6M | $5.8M | $7.6M | $2.7M | $1.3M | |
| Operating Income | -$28.3M | -$14.7M | -$13.5M | -$1.7M | -$3.2M | |
| EBITDA | -$21.3M | -$12.3M | -$12.8M | -$1.8M | -$4.1M | |
| Diluted EPS | -$7.46 | -$5.91 | -$4.02 | -$0.60 | -$1.00 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $107.8M | $88.5M | $39.9M | $24.5M | $14.8M | |
| Total Assets | $119.8M | $113.7M | $62.6M | $37.5M | $24.8M | |
| Current Liabilities | $13.8M | $18.6M | $9.1M | $9.2M | $8.9M | |
| Total Liabilities | $21.9M | $25.9M | $20M | $18.7M | $21.4M | |
| Total Equity | $97.9M | $87.8M | $42.6M | $18.8M | $3.4M | |
| Total Debt | $5.7M | $1.4M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$28.3M | -$13.9M | -$11.5M | -$3.7M | -$4.2M | |
| Cash From Investing | -$31.4M | $8.6M | $5.8M | -$371K | -$470K | |
| Cash From Financing | -$13.5M | $30K | $5.1M | -- | $3.7M | |
| Free Cash Flow | -$34.6M | -$15.1M | -$13.4M | -$4M | -$4.6M | |
XWEL
Sector
Market Cap
$5.4M
$426.2M
Price % of 52-Week High
37.78%
73.88%
Dividend Yield
0%
0%
Shareholder Yield
-95.04%
4%
1-Year Price Total Return
-38.92%
-11.07%
Beta (5-Year)
0.866
0.767
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.98
200-day SMA
Sell
Level
$1.22
Bollinger Bands (100)
Buy
Level
0.83 - 1.03
Chaikin Money Flow
Sell
Level
-10.3K
20-day SMA
Buy
Level
$0.96
Relative Strength Index (RSI14)
Buy
Level
59.61
ADX Line
Buy
Level
28.63
Williams %R
Neutral
Level
-20
50-day SMA
Buy
Level
$0.93
MACD (12, 26)
Buy
Level
0.27
25-day Aroon Oscillator
Buy
Level
4
On Balance Volume
Neutral
Level
50.5K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-25.7821)
Sell
CA Score
(Annual)
Level (-3.171)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (6.0836)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.
Stock Forecast FAQ
In the current month, XWEL has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The XWEL average analyst price target in the past 3 months is --.
-
Where Will XWELL Stock Be In 1 Year?
According to analysts, the consensus estimate is that XWELL share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About XWELL?
Analysts are divided on their view about XWELL share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that XWELL is a Sell and believe this share price will drop from its current level to --.
-
What Is XWELL's Price Target?
The price target for XWELL over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is XWEL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for XWELL is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of XWEL?
You can purchase shares of XWELL via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase XWELL shares.
-
What Is The XWELL Share Price Today?
XWELL was last trading at $1.06 per share. This represents the most recent stock quote for XWELL. Yesterday, XWELL closed at $1.02 per share.
-
How To Buy XWELL Stock Online?
In order to purchase XWELL stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
